ELAN FY 2022 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.4B-7.4% YoY

Gross Profit

$2.0B44.7% margin

Operating Income

$384M8.7% margin

Net Income

-$78M-1.8% margin

EPS (Diluted)

$-0.15

Cash Flow

Operating Cash Flow

$452M

Free Cash Flow

$268M

Stock-Based Comp.

$59M

Balance Sheet

Total Assets

$15.5B

Total Liabilities

$8.2B

Stockholders' Equity

$7.3B

Cash & Equivalents

$345M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.4B	$4.8B	-7.4%
Gross Profit	$2.0B	$2.1B	-5.1%
Operating Income	$384M	$304M	+26.3%
Net Income	-$78M	-$483M	+83.9%